89 related articles for article (PubMed ID: 3711932)
1. Successful treatment of murine muscular dystrophy with the protease inhibitor bestatin.
Tsuji S; Matsushita H
J Neurol Sci; 1986 Feb; 72(2-3):183-94. PubMed ID: 3711932
[TBL] [Abstract][Full Text] [Related]
2. [Experimental animal information file: effect of bestatin in muscular dystrophy in mice].
Kawamata J
Gan To Kagaku Ryoho; 1983 Nov; 10(11):2425-6. PubMed ID: 6639104
[No Abstract] [Full Text] [Related]
3. Beneficial effect of new thiol protease inhibitors, epoxide derivatives, on dystrophic mice.
Komatsu K; Inazuki K; Hosoya J; Satoh S
Exp Neurol; 1986 Jan; 91(1):23-9. PubMed ID: 3940877
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic trial with protease inhibitor (leupeptin) in chicken muscular dystrophy. A histologic and histochemical study.
Nonaka I; Ishiura S; Takagi A; Sugita H
Acta Neuropathol; 1982; 58(4):279-85. PubMed ID: 7158305
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic trials on progressive muscular dystrophy.
Satoyoshi E
Intern Med; 1992 Jul; 31(7):841-6. PubMed ID: 1450492
[TBL] [Abstract][Full Text] [Related]
6. The stabilizing effect of bestatin on the resting membrane potentials of X-linked muscular dystrophy mice.
Kishi M; Kurihara T; Hidaka T; Kinoshita M
Jpn J Psychiatry Neurol; 1990 Sep; 44(3):595-600. PubMed ID: 2074619
[TBL] [Abstract][Full Text] [Related]
7. Bortezomib partially improves laminin α2 chain-deficient muscular dystrophy.
Körner Z; Fontes-Oliveira CC; Holmberg J; Carmignac V; Durbeej M
Am J Pathol; 2014 May; 184(5):1518-28. PubMed ID: 24631023
[TBL] [Abstract][Full Text] [Related]
8. The relationships between enzyme inhibitors and function of mammalian cells.
Aoyagi T; Umezawa H
Acta Biol Med Ger; 1981; 40(10-11):1523-9. PubMed ID: 7044007
[TBL] [Abstract][Full Text] [Related]
9. Preclinical increase in activity of muscle microsomal trypsin-like protease in murine muscular dystrophy, C57BL/10-mdx.
Sawada H; Tsuji S; Kusumoto S; Doi Y; Matsushita H
FEBS Lett; 1986 Apr; 199(2):193-7. PubMed ID: 3516721
[TBL] [Abstract][Full Text] [Related]
10. A drug inhibits the mitochondrial protease inducing calmitine deficiency in skeletal muscle of patients with Duchenne's muscular dystrophy and dy/dy dystrophic mice.
Lucas-Heron B
Biochem Biophys Res Commun; 1997 Mar; 232(2):559-61. PubMed ID: 9125222
[TBL] [Abstract][Full Text] [Related]
11. Limited benefit to genetically dystrophic chickens from a synthetic proteinase inhibitor: Ep475.
Hudecki MS; Pollina CM; Heffner RR
J Neurol Sci; 1983 Jul; 60(1):55-66. PubMed ID: 6875613
[TBL] [Abstract][Full Text] [Related]
12. Improved muscle strength and mobility in the dy(2J)/dy(2J) mouse with merosin deficient congenital muscular dystrophy treated with Glatiramer acetate.
Dadush O; Aga-Mizrachi S; Ettinger K; Tabakman R; Elbaz M; Fellig Y; Yanay N; Nevo Y
Neuromuscul Disord; 2010 Apr; 20(4):267-72. PubMed ID: 20304648
[TBL] [Abstract][Full Text] [Related]
13. Calcium-activated neutral protease and its endogenous inhibitor in tissues of dystrophic and normal mice.
Rabbani N; Moses L; Anandaraj MP
Biochem Med Metab Biol; 1987 Jun; 37(3):282-6. PubMed ID: 3038152
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of copper/zinc superoxide dismutase: a novel cause of murine muscular dystrophy.
Rando TA; Crowley RS; Carlson EJ; Epstein CJ; Mohapatra PK
Ann Neurol; 1998 Sep; 44(3):381-6. PubMed ID: 9749606
[TBL] [Abstract][Full Text] [Related]
15. X chromosome-linked muscular dystrophy (mdx) in the mouse.
Bulfield G; Siller WG; Wight PA; Moore KJ
Proc Natl Acad Sci U S A; 1984 Feb; 81(4):1189-92. PubMed ID: 6583703
[TBL] [Abstract][Full Text] [Related]
16. Dissociation of creatine kinase activity from hydrolytic enzyme activities in muscle of dystrophic mice.
Aoyagi T; Wada T; Kojima F; Nagai M; Harada S; Saito M; Hioki K; Umezawa H
Biochem Int; 1985 Oct; 11(4):541-9. PubMed ID: 4084316
[TBL] [Abstract][Full Text] [Related]
17. Similar effects of various low-molecular-weight enzyme inhibitors on enzyme networks in dystrophic mice.
Aoyagi T; Wada T; Ohuchi S; Kojima F; Nagai M; Harada S; Umezawa H
J Pharmacobiodyn; 1984 Sep; 7(9):681-7. PubMed ID: 6527211
[TBL] [Abstract][Full Text] [Related]
18. [Effect of a cysteine protease inhibitor EST on urinary 3-methylhistidine in dystrophic hamsters (BIO 14.6)].
Terao T; Mashino K; Takatsu M; Hiraguchi M
Rinsho Shinkeigaku; 1986 Nov; 26(11):1218-23. PubMed ID: 3549099
[No Abstract] [Full Text] [Related]
19. Treatment of mouse muscular dystrophy with the protease inhibitor pepstatin.
Schorr EE; Arnason BG; Aström KE; Darzynkiewicz Z
J Neuropathol Exp Neurol; 1978 May; 37(3):263-8. PubMed ID: 660216
[TBL] [Abstract][Full Text] [Related]
20. Successful treatment of murine muscular dystrophy with the proteinase inhibitor leupeptin.
Sher JH; Stracher A; Shafiq SA; Hardy-Stashin J
Proc Natl Acad Sci U S A; 1981 Dec; 78(12):7742-4. PubMed ID: 6950412
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
